Triciribine Engages ZFP36L1 and HuR to Stabilize LDLR mRNA
An increased understanding of low-density lipoprotein receptor (LDLR) and its regulation may facilitate drug development for the treatment of hypercholesterolemia. Triciribine (TCN), which is a highly selective AKT inhibitor, increases the stability of LDLR mRNA downstream of extracellular signal-re...
Main Author: | Hilde Sundvold |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/25/19/4505 |
Similar Items
-
HuR (Elavl1) and HuB (Elavl2) Stabilize Matrix Metalloproteinase-9 mRNA During Seizure-Induced Mmp-9 Expression in Neurons
by: Katarzyna Zybura-Broda, et al.
Published: (2018-04-01) -
Cytoskeleton-dependent transport as a potential target for interfering with posttranscriptional HuR mRNA regulons
by: Wolfgang Eberhardt, et al.
Published: (2016-08-01) -
Therapeutic targets of hypercholesterolemia: HMGCR and LDLR
by: Ma S, et al.
Published: (2019-08-01) -
HuR (ELAVL1) Stabilizes <i>SOX9</i> mRNA and Promotes Migration and Invasion in Breast Cancer Cells
by: Jesús Morillo-Bernal, et al.
Published: (2024-01-01) -
The enigma of soluble LDLR: could inflammation be the key?
by: Majambu Mbikay, et al.
Published: (2020-02-01)